The efficacy of intravenous iron therapy in patients with inflammatory bowel disease associated iron deficiency anemia is not influenced by the degree of inflammatory activation
J Kunath, A Dignass, S Vollmer, W Klemm, S Weber-Mangal, F Hartmann, J Stein · Zeitschrift für Gastroenterologie · 2011 · Heft 08
Bibliografische Angaben
Zusammenfassung
Background/aim: Iron deficiency anemia (IDA) is a common complication of inflammatory bowel disease (IBD). Recent guidelines recommend that iron supplementation should be preferably administered intravenously in IBD patients (Gasche et al. IBD; 2007). However, data regarding the efficacy and safety of high dose intravenous iron administration in patients with chronic inflammatory diseases are conflicting. We studied body iron stores, hemoglobin, and degree of inflammation in patients with IBD-associated IDA treated with intravenous iron. Methods: Up to August 2010, 193 IBD patients (116 Crohn's disease [CD] and…